| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 84691 |
端乙炔基聚醚酰亚胺改性硅芳炔树脂（PEI-PSA） |
99 |
WYQ |
2024-11-22 |
| 84692 |
DOTA 偶联肽,NOTA-E(cRGDfK)2,NOTA标记多肽氨基酸试剂 |
132 |
kx |
2024-11-22 |
| 84693 |
Lutetium (177Lu) oxodotreotide；437608-50-9 |
84 |
wyh |
2024-11-22 |
| 84694 |
CAS：2125661-62-1 Butyne-DOTA |
91 |
zyl |
2024-11-22 |
| 84695 |
端乙炔基聚醚酰亚胺（PEI）（Polyetherimide，简称PEI） |
198 |
WYQ |
2024-11-22 |
| 84696 |
碳/聚硅乙炔基防热复合材料（C/PMR） |
112 |
WYQ |
2024-11-22 |
| 84697 |
聚（间二乙炔基苯-甲基氢硅烷）树脂（PSA） |
213 |
WYQ |
2024-11-22 |
| 84698 |
P-氨基苯乙炔基共轭侧基的聚对苯撑乙炔（PAnPE） |
95 |
WYQ |
2024-11-22 |
| 84699 |
DOTA-G5 DOTA修饰修饰第5代(G5)聚(酰胺基胺)树枝状聚合物 |
109 |
zcy |
2024-11-22 |
| 84700 |
DOTA-PEG5-azide 大环化合物-五聚乙二醇-叠氮 |
83 |
zyl |
2024-11-22 |
| 84701 |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, a-(2-carboxyethyl)-, 1,4,7,10-tetrakis(1,1-dimethylethyl) ester |
100 |
wyh |
2024-11-22 |
| 84702 |
DOTA功能化的聚赖氨酸 |
120 |
zcy |
2024-11-22 |
| 84703 |
聚乳酸-羟基乙酸共聚物-大环配体 |
114 |
wyh |
2024-11-22 |
| 84704 |
DOTA-Tyr3-thre8-奥曲肽 DOTA-Tyr3-Thre8-octreotide |
93 |
zcy |
2024-11-22 |
| 84705 |
1,4,7,10-Tetrakis(aminocarbonylmethyl)-1,4,7,10-tetraazacyclododecane |
85 |
wyh |
2024-11-22 |
| 84706 |
BKT140CXCR4 antagonist-DOTA |
97 |
zyl |
2024-11-22 |
| 84707 |
CAS:181065-46-3 p-NH2-Bn-DOTA(B-200) |
97 |
zyl |
2024-11-22 |
| 84708 |
DOTA di(tBu)ester；913542-71-9 |
107 |
wyh |
2024-11-22 |
| 84709 |
10,10'-[(5-硝基-1,3-苯基)双(亚甲基)]双[1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸]，三氟乙酸盐；1175002-77-3 |
89 |
wyh |
2024-11-22 |
| 84710 |
(R)-tert-Bu4-DOTAGA；817562-90-6 |
102 |
wyh |
2024-11-22 |
| 84711 |
DOTA-Bevacizumab DOTA-贝伐单抗 |
109 |
zcy |
2024-11-22 |
| 84712 |
10-[2-[(3,5-二羧基苯基)氨基]-2-氧乙基]-1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸，三氟乙酸盐 |
96 |
wyh |
2024-11-22 |
| 84713 |
DOTA接枝N-乙烯基吡咯烷酮-丙烯醛P(VP-Ac)共聚物 DOTA-VP-Ac |
97 |
zcy |
2024-11-22 |
| 84714 |
DOTA-HYNIC-IPSMA |
99 |
wyh |
2024-11-22 |
| 84715 |
PEG-GO 聚乙二醇化超小GO氧化石墨烯的二维纳米材料 |
206 |
zcy |
2024-11-22 |
| 84716 |
CAS1227407-76-2 叠氮基-单-酰胺-DOTA Azido-mono-amide-DOTA |
87 |
zyl |
2024-11-22 |
| 84717 |
(S)-N-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYL)-6-(METHYL(3-(PIPERAZIN-1-YL)PROPYL)AMINO)QUINOLINE-4-CARBOXAMIDE |
106 |
wyh |
2024-11-22 |
| 84718 |
DOTA(Tris)-EA-TEG-NH2-CBZ DOTA(Tris)-乙胺(EA)偶联四甘醇(TEG) |
155 |
zcy |
2024-11-22 |
| 84719 |
DOTA-octreotide,大环配体奥曲肽 |
126 |
zyl |
2024-11-22 |
| 84720 |
N2-Acetyl-N6-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-L-lysyl-L-prolyl-N2-methyl-L-arginyl-L-arginyl-L-prolyl-L-tyrosyl-3-methyl-L-valyl-L-leucine |
89 |
wyh |
2024-11-22 |
| 84721 |
DOTA-Ts29.2 DOTA偶联单克隆抗体Ts29.2 |
113 |
zcy |
2024-11-22 |
| 84722 |
DOTA-FAMP α螺旋肽偶联DOTA大环配体 |
107 |
zcy |
2024-11-22 |
| 84723 |
DOTA-NT8-13(靶向NTR1) |
109 |
zcy |
2024-11-22 |
| 84724 |
DOTA Conjugated JM#21 derivative 7 ；3033865-40-3 |
125 |
wyh |
2024-11-22 |
| 84725 |
4-Aminobutyl-DOTA-tris(t-butyl ester) Hexafluorophosphate |
85 |
wyh |
2024-11-22 |
| 84726 |
L-Threonine, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide |
85 |
wyh |
2024-11-22 |
| 84727 |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, 1-(2,5-dioxo-1-pyrrolidinyl) ester |
91 |
wyh |
2024-11-22 |
| 84728 |
DOTA-MC1RL 1，4，7，10-四氮杂环十二烷-1，4，7，10-四乙酸缀合MC1R特异性支架 |
113 |
zcy |
2024-11-22 |
| 84729 |
钆布醇杂质20 ；229312-34-9 |
136 |
wyh |
2024-11-22 |
| 84730 |
DOTA-[Nle]-cCCK 科研定制 |
129 |
zcy |
2024-11-22 |
| 84731 |
DOTA-(COOt-Bu)3-CH2-Alkynyl ；1189194-64-6 |
88 |
wyh |
2024-11-22 |
| 84732 |
FITC-PEG2-TATE ；1027160-33-3 |
110 |
wyh |
2024-11-22 |
| 84733 |
DOTA-peg4-LLP2AVLA-4 齐岳定制 |
99 |
zcy |
2024-11-22 |
| 84734 |
蛙皮素肽功能化金纳米颗粒 BBN-AuNPs |
98 |
zcy |
2024-11-22 |
| 84735 |
RGD-DOTA的结构特点 |
93 |
wyh |
2024-11-22 |
齐岳微信公众号
官方微信
库存查询